소룩스

290690KOSDAQ전구 및 조명장치 제조업

56.5 / 100

Reference Date: 2026-04-13

Financial Score21.0 / 40

News Sentiment16.5 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but Revenue is on a declining trend. Rose 12.8% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

SoLUX, established in 1996, is a company specializing in the manufacturing of electric lighting equipment and electrical/telecom construction services, operating through two business divisions: the Lighting Business Division and the Construction Business Division. The Lighting Business Division focuses on products like LED indoor lights, fluorescent lamps, and outdoor lighting, while the Construction Business Division, launched in 2025, expands into electrical and telecom construction projects.

Number of Employees

109people

Average Salary

38.8M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

1.94Industry Average 3.405.5Point

Lower than industry avg (good)

ROE

-9.12Industry Average -34.353.5Point

Well below industry avg

Debt Ratio

5.97Industry Average 20.138.0Point

Half of industry avg (excellent)

Trend 2023~20250.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼19.9% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼692.6% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -26.7% (improving, 3yr)

Detailed News Sentiment

5 totalPositive 4Neutral 0Negative 0Average Sentiment Score 70

Positive
[K-신약 혁신가들]① 하루 한알 치매약 도전...아리바이오 “임상 완...
아리바이오가 경구용 알츠하이머병 치료제 AR1001의 글로벌 임상 3상 막바지 단계에 있으며, 차백신연구소와의 시너지를 기대하고 있습니다.
Positive
아리바이오, ADPD 2026서 AR1001 글로벌 3상 성과 공개
아리바이오가 ADPD 2026에서 AR1001 글로벌 3상 성과를 공개하며 높은 신뢰도와 안전성을 확보했다고 밝혔습니다.
Positive
아리바이오, 알츠하이머병 치료제 AR1001 3상 설계 타당성 및 안...
아리바이오가 알츠하이머병 치료제 AR1001 3상 설계 타당성 및 안전성을 발표하며 경구 치료제 중 세계 최대 규모 임상임을 강조했습니다.

Detailed Momentum

52-week position3.0Point

52w lower range (27%)

Current 3,615Won52-week high 5,94052-week low 2,720

1-month return5.0Point

1m +12.79% (rising)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

26 totalPositive 0Neutral 26Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-04-02
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-02
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-02
Neutral주요사항보고서(자기전환사채매도결정)2026-03-31
Neutral전환청구권행사 (제3회차 CB))2026-03-31